Physician profile
James B Manning
NPI 1871588996
$6,161.18
in general payments reported to CMS, 2019-2025
11 companies · $422 in 2025
The $422 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,700 · 2020: $149 · 2021: $236 · 2022: $1,521 · 2023: $405 · 2024: $1,728 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,681 · Food and Beverage: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,680.90 |
| Food and Beverage | $873.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $2,860.58 | 2019-2025 | |
| Arthrex, INC. | $2,263.57 | 2022-2024 | |
| Smith+Nephew, INC. | $444.16 | 2019-2025 | Journey II, Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Embody, INC. | $188.71 | 2021 | |
| Stryker Corporation | $152.48 | 2019-2025 | Alphavent |
| Pacira Therapeutics, INC. | $138.11 | 2019 | |
| Nevro Corp. | $33.83 | 2024 | Senza |
| Si-Bone, INC. | $30.04 | 2024 | |
| Zimmer Biomet Holdings, INC. | $18.82 | 2020 | |
| Ethicon US, LLC | $16.46 | 2020 | |
| Medtronic, INC. | $14.42 | 2023 | Aquamantys(Tm) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.